The anxiolytic effects of valtrate in rats involves changes of corticosterone levels

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Shi, Shu Ning ^a   Shi, Jin Li ^a   Liu, Yong ^a   Wang, Yan Li ^a   Wang, Chun Guo ^a   Hou, Wen Hui ^a   Guo, Jian You ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; DIAZEPAM; VALTRATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; DRUG ISOLATION; ELECTROSPRAY MASS SPECTROMETRY; ELEVATED PLUS MAZE TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TRANQUILIZING ACTIVITY; TREATMENT DURATION; VALERIANA; VALERIANA JATAMANSI;

EID: 84897550096     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/325948     Document Type: Article

References (38)

1. Reynolds E. H., Brain and mind: a challenge for WHO. The Lancet 2003 361 9373 1924 1925 2-s2.0-0037529138 10.1016/S0140-6736(03)13600-8 (Pubitemid 36694577)
2. Woods J. H., Katz J. L., Winger G., Benzodiazepines: use, abuse, and consequences. Pharmacological Reviews 1992 44 2 155 338 2-s2.0-0026878098
3. Paterniti S., Dufouil C., Alpérovitch A., Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. Journal of Clinical Psychopharmacology 2002 22 3 285 293 2-s2.0-0036107859 10.1097/00004714-200206000-00009 (Pubitemid 34546844)
4. Ravindran L. N., Stein M. B., The pharmacologic treatment of anxiety disorders: a review of progress. The Journal of Clinical Psychiatry 2010 71 7 839 854 2-s2.0-77955302215 10.4088/JCP.10r06218blu
5. Guo J.-Y., Han C.-C., Liu Y.-M., A contemporary treatment approach to both diabetes and depression by cordyceps sinensis, Rich in Vanadium. Evidence-Based Complementary and Alternative Medicine 2010 7 3 387 389 2-s2.0-77953848897 10.1093/ecam/nep201
6. Zheng H. Z., Shi J. L., Anxiolytic-like effects of compound zhi zhu xiang Capsule about anxiety disorders of learning in clinical. Modern Journal of Integrated Traditional Chinese and Western Medicine 2012 30 3395 3396
7. Yan Z. Y., Zhang T. E., Peng J., Zhang Z. P., Qin J. Z., Chen C., Effect of the extract of Valeriana jatamansi Jones on the ethology and neurotransm itter in the brain in the anxietymodel of rat. Pharmacology and Clinics of Chinese Materia Medica 2008 24 67 69
8. Li S.-H., Yan Z.-Y., Research of iridoids from Valeriana jatamansi Jones. Chinese Journal of New Drugs 2012 21 6 633 637 2-s2.0-84860014108
9. Fuzzati N., Wolfender J. L., Hostettmann K., Msonthi J. D., Mavi S., Molleyres L. P., Isolation of antifungal valepotriates from Valeriana capense and the search for valepotriates in crude Valerianaceae extracts. Phytochemical Analysis 1996 7 2 76 85 (Pubitemid 26080024)
10. Keochanthala-Bounthanh C., Beck J. P., Haag-Berrurier M., Anton R., Effects of two monoterpene esters, valtrate and didrovaltrate, isolated from Valeriana wallichii, on the ultrastructure of hepatoma cells in culture. Phytotherapy Research 1993 7 2 124 127 2-s2.0-0027401085 (Pubitemid 23106463)
11. Keochanthala-Bounthanh C., Haag-Berrurier M., Beck J. P., Anton R., Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. Planta Medica 1990 56 2 190 192 2-s2.0-0025283684 10.1055/s-2006-960923 (Pubitemid 20168053)
12. Bounthanh C., Bergmann C., Beck J. P., Haag-Berrurier M., Anton R., Valepotriates, a new class of cytotoxic and antitumor agents. Planta Medica 1981 41 1 21 28 2-s2.0-0019352751 (Pubitemid 11183382)
13. Chen L., Kang L. P., Qin L. P., Zheng H. C., Guo C., The sedative activity of the Valepotriates in mice. Chinese Traditional Patent Medicine 2003 25 8 663 665
14. Dawson G. R., Tricklebank M. D., Use of the elevated plus maze in the search for novel anxiolytic agents. Trends in Pharmacological Sciences 1995 16 2 33 36 2-s2.0-0028934728 10.1016/S0165-6147(00)88973-7
15. Millan M. J., The neurobiology and control of anxious states. Progress in Neurobiology 2003 70 2 83 244 2-s2.0-0142216081 10.1016/S0301-0082(03)00087-X (Pubitemid 37309295)
16. Brotto L. A., Barr A. M., Gorzalka B. B., Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. European Journal of Pharmacology 2000 402 1-2 87 93 2-s2.0-0034683204 10.1016/S0014-2999(00)00491-X (Pubitemid 30625314)
17. Belzung C., Griebel G., Measuring normal and pathological anxiety-like behaviour in mice: a review. Behavioural Brain Research 2001 125 1-2 141 149 2-s2.0-0035829390 10.1016/S0166-4328(01)00291-1 (Pubitemid 33000452)
18. Wang Y. L., Shi J. L., Yong L., Zhao R., Zhai Y. J., Guo J. Y., Anxiolytic-like effects of compound Zhi Zhu Xiang in rats. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 701289 10.1155/2012/701289
19. Polissidis A., Chouliara O., Galanopoulos A., Rentesi G., Dosi M., Hyphantis T., Marselos M., Papadopoulou-Daifoti Z., Nomikos G. G., Spyraki C., Tzavara E. T., Antoniou K., Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain. The International Journal of Neuropsychopharmacology 2010 13 9 1175 1191 2-s2.0-77957236773 10.1017/S1461145709991003
20. Lister R. G., Ethologically-based animal models of anxiety disorders. Pharmacology and Therapeutics 1990 46 3 321 340 2-s2.0-0025321231 (Pubitemid 20108519)
21. Thies P. W., Die konstitution der valepotriate. Mitteilung über die wirkstoffe des baldrians. Tetrahedron 1968 24 1 313 347 2-s2.0-0000563556
22. Walsh R. N., Cummins R. A., The open-field test: a critical review. Psychological Bulletin 1976 83 3 482 504 2-s2.0-0000650706 10.1037/0033-2909.83. 3.482
23. Sherif F., Harro J., El-Hwuegi A., Oreland L., Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA) on rat exploratory activity. Pharmacology Biochemistry and Behavior 1994 49 4 801 805 2-s2.0-0028062135 10.1016/0091-3057(94)90226-7 (Pubitemid 24376013)
24. Ang H. H., Cheang H. S., Studies on the anxiolytic activity of Eurycoma longifolia Jack roots in mice. Japanese Journal of Pharmacology 1999 79 4 497 500 2-s2.0-0032957385 10.1254/jjp.79.497 (Pubitemid 29213370)
25. Prut L., Belzung C., The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 2003 463 1-3 3 33 2-s2.0-0037470154 10.1016/S0014-2999(03)01272-X (Pubitemid 36205070)
26. Rentesi G., Antoniou K., Marselos M., Fotopoulos A., Alboycharali J., Konstandi M., Long-term consequences of early maternal deprivation in serotonergic activity and HPA function in adult rat. Neuroscience Letters 2010 480 1 7 11 2-s2.0-77954385190 10.1016/j.neulet.2010.04.054
27. Bhattacharya S. K., Mitra S. K., Anxiolytic activity of Panax ginseng roots: an experimental study. Journal of Ethnopharmacology 1991 34 1 87 92 2-s2.0-0025832111
28. Hasenöhrl R. U., Nichau C., Frisch C., De Souza Silva M. A., Huston J. P., Mattern C. M., Häcker R., Anxiolytic-like effect of combined extracts of Zingiber officinale and ginkgo biloba in the elevated plus-maze. Pharmacology Biochemistry and Behavior 1996 53 2 271 275 2-s2.0-0342313461 10.1016/0091-3057(95)02001-2 (Pubitemid 26060766)
29. Guo J.-Y., Li C.-Y., Ruan Y.-P., Sun M., Qi X.-L., Zhao B.-S., Luo F., Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. European Journal of Pharmacology 2009 612 1-3 54 60 2-s2.0-65549129726 10.1016/j.ejphar.2009.03.076
30. Yan Z. Y., Zhang T. E., Xiao T., Pan L. Z., Qin J. Z., Zhang Z. P., Zuo C. Y., Anti-anxiety effect of Valeriana jatamansi Jones extract via regulation of hypothalamus-pituitary-adrenal axies. Neural Regeneration Research 2010 14 1071 1075
31. Basedovsky H., Sorkin E., Network of immune neuroendocrine interactions. Clinical & Experimental Immunology 1977 27 1 1 22
32. Rodgers R. J., Haller J., Holmes A., Halasz J., Walton T. J., Brain P. F., Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiology and Behavior 1999 68 1-2 47 53 2-s2.0-0033430166 10.1016/S0031-9384(99)00140-7 (Pubitemid 30009781)
33. Amaral V. C. S., Santos Gomes K., Nunes-de-Souza R. L., Increased corticosterone levels in mice subjected to the rat exposure test. Hormones and Behavior 2010 57 2 128 133 2-s2.0-74749106453 10.1016/j.yhbeh.2009.09.018
34. Venâncio E. T., Rocha N. F. M., Rios E. R. V., Feitosa M. L., Linhares M. I., Melo F. H. C., Matias M. S., Fonseca F. N., Sousa F. C. F., Leal L. K. A. M., Fonteles M. M. D. F., Anxiolytic-like effects of standardized extract of Justicia pectoralis (SEJP) in mice: involvement of GABA/benzodiazepine in receptor. Phytotherapy Research 2011 25 3 444 450 2-s2.0-79551627498 10.1002/ptr.3274
35. Miguel C. J., Juan F. R. L., Maria L. R. P., The aqueous crude extract of Montanoa frutescens produces anxiolytic-like effects similarly to diazepam in Wistar rats: involvement of GABAA receptor. Journal of Ethnopharmacology 2012 143 2 592 598
36. You J. S., Peng M., Shi J. L., Zheng H. Z., Liu Y., Zhao B. S., Guo J. Y., Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice. BMC Complementary and Alternative Medicine 2012 12 223
37. Pellow S., Chopin P., File S. E., Briley M., Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 1985 14 3 149 167 2-s2.0-0022374863 (Pubitemid 16239568)
38. Cullinan W. E., Ziegler D. R., Herman J. P., Functional role of local GABAergic influences on the HPA axis. Brain Structure and Function 2008 213 1-2 63 72 2-s2.0-50249092178 10.1007/s00429-008-0192-2